About this trial

The communication of an altered Pap smear or positive HPV test has a strong impact on patients on a psychological level. HPV positive women are more likely to have higher level of stress, anxiety, depression and impaired sexual life.

The examiner want to establish this impact through different surveys (DASS-21 (Depression Anxiety Stress Scales); PCL-5 (Posttraumatic Stress Disorder Checklist); DTS (Dyadic Trust Scale), CDDQ (Cervical Dysplasia Distress Questionnaire) and MPI (Match Patient Inventory) from the moment the patient receives the news until after completing treatment for her intraepithelial neoplasia.

Eligibility criteria

Qualifiers

patients accessing our Colposcopy service from Prevenzione Serena program with an altered pap smear or a two-times positive HPV test

patients with biopsy result of HSIL

ability to fill in surveys via e-mail

Disqualifiers

previous access in our Colposcopy service

patients not enrolled in Prevenzione Serena

pregnant patients

inability to fill in surveys via email

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

300 Participants
are grouped into 2 trial groups

Locations

1
Ospedale Sant'Anna10126, TurinTO, Italy

Sponsors and collaborators

University of Turin, Italy

Lead sponsor